Adherence to medication.

  title={Adherence to medication.},
  author={Lars G Osterberg and Terrence F. Blaschke},
  journal={The New England journal of medicine},
  volume={353 5},
The full benefit of many effective medications will be achieved only if patients adhere to prescribed treatment regimens. Unfortunately, applying terms such as “noncompliant” and “nonadherent” to patients who do not consume every pill at the desired time can stigmatize them in their future relationships with health care providers. This article on medication adherence (or compliance) reviews strategies to assess and enhance this important aspect of patient care. 

Figures and Tables from this paper

Adherence to medications: Towards a shared understanding
Patient adherence to medication is a complex issue that is important to patients, health professionals, policy makers and health researchers. This article will provide some background to the
Refill adherence to long-term drug treatment with a focus on asthma/COPD medication.
Most patients are non-adherent with their medication sometimes, i.e. that they do not always use their medicines as prescribed. This might result in both under- and overuse and can lead to therapy ...
Reasons for Nonadherence
Addressing common reasons for nonadherence can improve adherence and overall treatment outcome and help providers anticipate how patients will incorporate treatment into their daily routine.
Adherence: The Great Masquerader of Treatment-Resistance
It is common in research studies of adherence to categorize a patient as adherent if they take at least 80 % of their prescribed medication.
Patient medication adherence: measures in daily practice.
Barriers to adherence could be addressed as patient, provider and health system factors, with interactions among them, and identifies specific barriers for each patient and adopting suitable techniques to overcome them.
Medication adherence: Scope of the problem, ways to measure, ways to improve, and the role of the pharmacist
A large number of Americans do not take their prescribed medications as intended, which results in suboptimal clinical outcomes and financial strains on the health care system.
The potential impact of pharmacogenetic testing on medication adherence
The potential impact (positively or negatively) of PGx testing on medication-taking behavior is considered.
[Medication adherence and monitoring of antihypertensive treatment].
An updated overview of methods of revealing and monitoring medication adherence is provided, based on non-systematic literature searches in PubMed and on the senior authors' own clinical experience.
Adherence to antihypertensive medication and association with patient and practice factors
No significant associations were discovered between adherence to medication and socio-demographic variables, comorbidities or number of antihypertensive drugs taken and further research is needed to identify effective interventions to enhance patient medication adherence.
The Role of Adherence in Pharmaceutical Care
This chapter starts by defining and carefully framing medication adherence and placing the different terms and phases of the “patient-medicine relationship” into context, and provides an overview of the factors that impact on medication adherence, the methods available to measure adherence, and above all, the ways through which practitioners may detect medication non-adherence in daily practice.


Adherence to treatment and health outcomes.
It is now believed that the outcomes of treatment are not solely attributable to the specific action of a drug, but may also depend on other nonspecific therapeutic effects.
[Methods to improve patient compliance in the use of antidepressants].
Research has shown that interventions that enhance compliance can lead to a better outcome of the depression and a structured treatment programme in which the patient actively participates can improve compliance.
Compliance declines between clinic visits.
Data indicate that spot drug levels do not represent long-term "steady-state" drug serum concentrations, and adherence to prescribed drug dosing regimens declined substantially during the interval between clinic visits and drug level tests.
A Comparison Study of Multiple Measures of Adherence to HIV Protease Inhibitors
Using HIV viral load as a clinical criterion, methods of measuring adherence to antiretroviral therapy among HIV-infected patients were compared, a composite adherence score (CAS) was developed, and the associations between each adherence measure and viral load were analyzed.
Measurement of Adherence to Antiretroviral Medications
Measurement of adherence may be important in determining why patients fail antiretroviral therapy, and a composite adherence score has been developed that uses electronic monitoring, pill counts, and patient self‐report.
Associations with medication adherence among ethnically different pediatric patients with renal transplants
Perceived characteristics of their medication regimen, including pill size, pill taste and medication complexity, were found to have significantly low to moderate associations with medication adherence among African American and European American pediatric renal transplant patients.
Overview of patient compliance with medication dosing: a literature review.
Once- a-day and twice-a-day regimens were associated with significantly better compliance than were three- times-daily and four-times-daily regimens.
Compliance/adherence and care management in HIV disease.
  • M. Crespo-Fierro
  • Medicine, Political Science
    The Journal of the Association of Nurses in AIDS Care : JANAC
  • 1997
Adherence to HAART among patients with HIV: Breakthroughs and barriers
Overall, multifaceted interventions appear most promising in adherence to HAART, with recommendations to enhance clinical practice and improve treatment outcomes for patients with HIV.
Hypertension and current issues in compliance and patient outcomes
The use of health-related quality of life assessment in antihypertensive studies and in routine clinical practice provides another opportunity to optimize a patient’s regimen for short-and long-term hypertension control in a cost-effective manner.